Teleflex's vascular positioning device wins FDA nod

04/29/2013 | RTT News

The FDA has cleared Teleflex to market its ARROW VPS G4 Device, which could be released in the U.S. during the second quarter of the year. The system is said to be the only such device designed to pinpoint the exact site of the lower 1/3 of the vena cava and cavo-atrial junction using micro-Doppler ultrasound combined with advanced algorithms and intravascular ECG.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Actuary
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI